The efficacy of TZD to reduce arterial pressure depending upon magnitude of renin–angiotensin II pathway activation may, by analogy, suggest that hypertension associated with high sympathetic nervous system activity is insensitive to arterial pressure reduction. The gene discussed is REN; the disease is Hypertension.